Cortexin Research for Stroke Recovery
An evidence-based overview of research examining Cortexin in the context of stroke recovery. This page synthesizes findings from peer-reviewed literature.
Research Summary
Cortexin has been studied in Russia for post-stroke recovery. Animal studies demonstrate neuroprotective effects in ischemia models (Silachev et al., 2021). Russian clinical trials report improvements in neurological outcomes, though these lack independent Western validation. No FDA-approved indications exist.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Stroke Recovery
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Cortexin may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.